Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Verrica Pharmaceuticals (VRCA) Insider Trading & Ownership

Verrica Pharmaceuticals logo
$5.87 -0.40 (-6.38%)
Closing price 05/18/2026 04:00 PM Eastern
Extended Trading
$5.82 -0.05 (-0.94%)
As of 06:42 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Verrica Pharmaceuticals (NASDAQ:VRCA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
54.00%
Number Of
Insiders Buying
(Last 12 Months)
5
Amount Of
Insider Buying
(Last 12 Months)
$17.96M
Number Of
Insiders Selling
(Last 12 Months)
0
Get VRCA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Verrica Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VRCA Insider Buying and Selling by Quarter

Verrica Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/25/2025
David Zawitz
COO
Buy10,000$4.24$42,400.00  
11/25/2025
Jayson Rieger
CEO
Buy94,311$4.24$399,878.64  
11/25/2025
John J Kirby
CFO
Buy3,536$4.24$14,992.64  
11/25/2025
Noah L Rosenberg
CMO
Buy2,357$4.24$9,993.68  
11/25/2025Buy1,375,380$4.24$5,831,611.20  
11/25/2025Buy2,750,762$4.24$11,663,230.88  
(Data available from 1/1/2013 forward)

VRCA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Verrica Pharmaceuticals includes Christopher G Hayes, David Zawitz, Jayson Rieger, Joe Bonaccorso, John J Kirby, Noah L Rosenberg, Paul B Manning, Perceptive Advisors Llc, and Ted White. Learn more on insiders at VRCA.

54.00% of Verrica Pharmaceuticals stock is owned by insiders. Learn more on VRCA's insider holdings.

The following insiders have purchased VRCA shares in the last 24 months: David Zawitz ($42,400.00), Jayson Rieger ($399,878.64), John J Kirby ($14,992.64), Noah L Rosenberg ($9,993.68), and Paul B Manning ($17,494,842.08).

Insiders have purchased a total of 4,236,346 VRCA shares in the last 24 months for a total of $17,962,107.04 bought.

The following insiders have sold VRCA shares in the last 24 months: Christopher G Hayes ($2,801.50), Joe Bonaccorso ($179,747.60), and Ted White ($229,167.60).

Insiders have sold a total of 6,223 Verrica Pharmaceuticals shares in the last 24 months for a total of $411,716.70 sold.



This page (NASDAQ:VRCA) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners